These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3719898)
1. Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine. Bore P; Lena N; Imbert AM; Favre R; Cano JP; Meyer G; Carcassonne Y Cancer Chemother Pharmacol; 1986; 17(2):171-6. PubMed ID: 3719898 [TBL] [Abstract][Full Text] [Related]
2. Methotrexate-vindesine association in the treatment of head and neck cancer influence of vindesine on methotrexate's pharmacokinetic behavior. Lena N; Imbert AM; Pignon T; Favre R; Meyer G; Cano JP; Carcassonne Y Cancer Chemother Pharmacol; 1984; 12(2):120-4. PubMed ID: 6697425 [TBL] [Abstract][Full Text] [Related]
3. Methotrexate-vindesine association in leukemia: pharmacokinetic study. Tubiana N; Lena N; Barbet J; Imbert AM; Lejeune C; Maraninchi D; Sainty D; Sebahoun G; Gastaut JA; Cano JP Med Oncol Tumor Pharmacother; 1985; 2(2):99-102. PubMed ID: 3864001 [TBL] [Abstract][Full Text] [Related]
4. The effect of vindesine on methotrexate hydroxylation in the rat. Bremnes RM; Smeland E; Slørdal L; Wist E; Aarbakke J Biochem Pharmacol; 1991 Sep; 42(8):1561-8. PubMed ID: 1930283 [TBL] [Abstract][Full Text] [Related]
5. Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3. Huang C; Xia F; Xue L; Liu L; Bian Y; Jin Z; Miao L Cancer Chemother Pharmacol; 2020 Feb; 85(2):433-441. PubMed ID: 31691080 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate test-dose protocol in the presence of 7-hydroxy-methotrexate. Lena N; Imbert AM; Favre R; Cano JP; Carcassonne Y Eur J Cancer Clin Oncol; 1987 May; 23(5):481-5. PubMed ID: 3477455 [TBL] [Abstract][Full Text] [Related]
7. A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer. Tellez-Bernal E; Recondo G; Guillot T; Benhamed M; Domenge C; Izzo J; Cvitkovic E; Armand JP Cancer; 1990 Aug; 66(4):640-4. PubMed ID: 2386892 [TBL] [Abstract][Full Text] [Related]
8. A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial. Olivier G; Clavert A; Lacotte-Thierry L; Gardembas M; Escoffre-Barbe M; Brion A; Cumin I; Legouffe E; Solal-Celigny P; Chabin M; Ingrand P; Colombat P; Delwail V Am J Hematol; 2014 Nov; 89(11):1024-9. PubMed ID: 25052698 [TBL] [Abstract][Full Text] [Related]
9. High-dose methotrexate: preliminary evaluation of a pharmacokinetic approach. Monjanel S; Rigault JP; Cano JP; Carcassonne Y; Favre R Cancer Chemother Pharmacol; 1979; 3(3):189-96. PubMed ID: 527209 [TBL] [Abstract][Full Text] [Related]
10. [Cytostatic therapy of advanced squamous cell carcinoma of the head and neck. A randomized study comparing cis-dichlorodiammineplatinum(II) and bleomycin with methotrexate and vindesine]. von Heyden HW; Schröder M; Scherpe A; Beyer JH; Kaboth U; Stennert E; Nagel GA; Gerhartz H; Foth B; Kastenbauer E Onkologie; 1984 Jun; 7(3):183-90. PubMed ID: 6205337 [TBL] [Abstract][Full Text] [Related]
11. [Five-day continuous infusion of vindesine in the treatment of non-small cell lung cancer--clinical pharmacokinetics of vindesine]. Saito Y; Mori K; Tominaga K; Yokoi K; Miyazawa N Gan To Kagaku Ryoho; 1991 Sep; 18(12):2129-32. PubMed ID: 1653559 [TBL] [Abstract][Full Text] [Related]
12. [Neo-adjuvant chemotherapy with cisplatin, 5-fluorouracil, vindesine in head and neck cancer]. Terazono T; Oshima W; Kihira S; Takegami E; Kume T; Doi R; Nakao M; Takada A Gan To Kagaku Ryoho; 1992 Feb; 19(2):211-5. PubMed ID: 1736833 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs. Sørensen JB; Hansen HH; Dombernowsky P; Bork E; Malmberg R; Aabo K; Bødker B; Hansen M J Clin Oncol; 1987 Aug; 5(8):1169-77. PubMed ID: 3040918 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid. Morikawa N; Mori T; Abe T; Ghoda M; Takeyama M; Hori S Ann Pharmacother; 1997 Oct; 31(10):1153-6. PubMed ID: 9337440 [TBL] [Abstract][Full Text] [Related]
15. [2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine]. Schröder M; von Heyden HW; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Kastenbauer E; Westerhausen M; Schroeder M; Caliebe W; Rudert H; Lissers R; Hofmann J; Schneider B Onkologie; 1983 Jun; 6(3):114-7. PubMed ID: 6193472 [TBL] [Abstract][Full Text] [Related]
16. No influence of enzyme inhibitors on the hydroxylation of methotrexate in rats. Yu D; Brasch H; Iven H Cancer Lett; 1989 Nov; 48(2):153-6. PubMed ID: 2819703 [TBL] [Abstract][Full Text] [Related]